| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5631e8f02d186b06e61d5611699397a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61f88efcda59d7062a4252ecf6886f58 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate |
2012-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d305aea4384f0bde8c53d9a15cb33f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e39b27f5036d1a375964c002dd0b7b25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c85713b6e8db5f8429bbd49dc532013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df331a3fbc43c9c7a4d703806084c74e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68d4d2934ff351981e9b8355be04345c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_165d103dcec70c23a3d8f9283ac6c746 |
| publicationDate |
2014-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-104039786-A |
| titleOfInvention |
PAK inhibitors for the treatment of fragile X syndrome |
| abstract |
Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of Fragile X syndrome. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107083428-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107083428-B |
| priorityDate |
2011-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |